+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comorbidity of schizophrenia and substance abuse: implications for treatment

Comorbidity of schizophrenia and substance abuse: implications for treatment

Journal of Consulting and Clinical Psychology 60(6): 845-856

The problem of substance abuse disorders in schizophrenia patients is reviewed, including the prevalence of co-morbid disorders, assessment, hypothesized mechanisms underlying abuse, and the clinical effects of abuse on the course of illness and cognitive functioning. The principles of treatment for dual-diagnosis schizophrenia patients are outlined, and the limitations of existing interventions are noted. Gaps in current knowledge about the impact of substance abuse on schizophrenia and its treatment are identified, and suggestions are made regarding promising avenues of research in this area.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 039614159

Download citation: RISBibTeXText

PMID: 1460148

DOI: 10.1037/0022-006x.60.6.845

Related references

Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 51(8): 531-539, 2006

Risperidone versus zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity: a long-term randomized, controlled, crossover study. European Journal of Psychiatry 20(3): 133-146, 2006

Substance abuse comorbidity in schizophrenia. Schizophrenia Bulletin 16(1): 29-132, 1990

A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry 50(2): 71-83, 2001

Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychological Medicine 22(2): 379-388, 1992

Demographic and clinical correlates of substance abuse comorbidity in schizophrenia. Indian Journal of Psychiatry 46(2): 135-139, 2004

Schizophrenia and substance abuse comorbidity: nicotine addiction and the neonatal quinpirole model. Developmental Neuroscience 34(2-3): 140-151, 2012

Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. American Journal of Psychiatry 151(3): 385-389, 1994

Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse. Psychopharmacology 112(1 Suppl): S68-S75, 1993

Substance use disorders in schizophrenia--clinical implications of comorbidity. Schizophrenia Bulletin 35(3): 469-472, 2009

Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?. International Journal of Neuropsychopharmacology 10(4): 547-555, 2007

Motivational disturbances following neonatal ventral hippocampal lesions A neurobiological model for substance abuse comorbidity in schizophrenia. Society for Neuroscience Abstracts 27(2): 2330, 2001

Personality characterizations of outpatients with schizophrenia, schizophrenia with substance abuse, and primary substance abuse. Journal of Nervous and Mental Disease 192(10): 672-681, 2004

PTSD substance abuse comorbidity and treatment utilization. Addictive Behaviors. 20(2): 251-254, 1995

Tobacco use and psychiatric comorbidity among adolescents in substance abuse treatment. Journal of Substance Abuse Treatment 43(1): 20-29, 2012